Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report
By
Yanling Yuan
Wanming He
Lihua Tong
Yu Yang
Wen Yang
June 17, 2026
Clinical Scorecard: Multimodal Treatment Approach Facilitating Definitive Surgery in a High-Risk FIGO Stage IVA Cervical Cancer Patient: A Case Study
At a Glance
Category Detail
Condition FIGO stage IVA cervical cancer Key Mechanisms Multimodal treatment including radiotherapy, targeted therapy, immunotherapy, and consolidation chemotherapy. Target Population Patients with FIGO stage IVA cervical cancer presenting with severe complications. Care Setting Oncology and radiotherapy units.
Key Highlights
Patient presented with massive vaginal bleeding and renal dysfunction. Emergency hemostatic radiotherapy achieved rapid bleeding control. Individualized multimodal strategy led to marked tumor regression. Definitive radical surgery resulted in pathologic complete response. Adaptive replanning of radiotherapy minimized radiation exposure to adjacent organs. Guideline-Based Recommendations
Diagnosis
Comprehensive evaluation including imaging and biopsy for staging. Management
Utilize multimodal treatment strategies for high-risk patients. Monitoring & Follow-up
Serial imaging and adaptive replanning during treatment. Risks
High risk of treatment-related fistula formation and compromised quality of life. Patient & Prescribing Data
High-risk FIGO stage IVA cervical cancer patients.
Combination of radiotherapy and immunotherapy may enhance treatment efficacy.
Clinical Best Practices
Implement individualized treatment plans based on patient condition. Incorporate IGRT for monitoring and adaptive treatment planning. Prioritize emergency interventions for severe complications. Related Resources & Content
